TAKEDA DEVELOPMENT CENTRE EUROPE LTD. -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:500-600
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 10
As coordinator: 0
As participant: 10
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 146.802.130 0 9
2018 0 1.750.000 0 1

Networking:

Partners:

Institution:Projects [No]:
TAKEDA PHARMACEUTICALS INTERNATIONAL10
JANSSEN PHARMACEUTICA NV8
PFIZER LIMITED7
SANOFIAVENTIS7
ELI LILLY AND COMPANY LIMITED6
NOVARTIS PHARMA6
ASTRAZENECA5
BAYER5
UCB BIOPHARMA5
ACADEMISCH ZIEKENHUIS GRONINGEN4
F HOFFMANNLA ROCHE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
KAROLINSKA INSTITUTE3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
STICHTING LYGATURE3
STICHTING VUMC3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF CAMBRIDGE3
ABBVIE INC2
ALZHEIMER EUROPE2
AMGEN LIMITED2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
DREEM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
IXSCIENT LIMITED2
MCROBERTS BV2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
NOVO NORDISK2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
STICHTING MLC FOUNDATION2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
TTOPSTART BV2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF NEWCASTLE UPON TYNE2
VIB VZW2
VITAL TRANSFORMATION2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA REGIONALE DI SANITA1
ALACRIS THERANOSTICS1
ALLERGAN LIMITED1
ALTOIDA1
ANTAROS MEDICAL AB1
ARTTIC1
ARTTIC INNOVATION1
ASOCIACION PARKINSON MADRID1
ASTELLAS PHARMA EUROPE BV1
ATRYS HEALTH1
AZIENDA OSPEDALE UNIVERSITA PADOVA1
AZIENDA OSPEDALIEROUNIVERSITARIA ANNA MEYER1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
BIOGEN IDEC LIMITED1
BIONEER1
BIONOTUS1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
BYTEFLIES1
CAMBRIDGE COGNITION LIMITED1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CLINIQUES UNIVERSITAIRES SAINTLUC1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
COVANCE CLINICAL AND PERIAPPROVAL SERVICES1
COVANCE LABORATORIES1
DEPARTMENT OF HEALTH1
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN1
DRESDEN UNIVERSITY OF TECHNOLOGY1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECLINICALHEALTH1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ELEVATE BV1
ELLEGAARD GOTTINGEN MINIPIGS AS1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERESEARCH TECHNOLOGY INC1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING1
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1

Constancy:

Total number of partners: 313
Partner loyalty:
Frequent Partner: (> 2 projects): 101
Rare Partner: 212
Frequent / Rare Partner Ratio: 0.48

Project overview: